- Food & Drink
- Travel & Lifestyle
- Arts & Culture
- News & City Info
Start your day off right with five things you need to know this morning.
Five things you need to know
Kanye West has been ordered to pay his ex-wife, Kim Kardashian, US$200,000 every month in child support. Kardashian filed for divorce in 2021 after eight years with West.
Kim Kardashian’s divorce from Ye has been finalized, with the rapper formerly known as Kanye West agreeing to pay her $200,000 a month in child support, court documents show. https://t.co/NzEQfQ9IlA— NBC News (@NBCNews) November 30, 2022
UNESCO has added the French baguette to its list of traditions deemed to represent the world's "intangible cultural heritage." The list's credibility is questionable, however, given its failure to include poutine.
The humble baguette — the crunchy ambassador for French baking around the world — is being added to the U.N.'s list of intangible cultural heritage as a cherished tradition to be preserved by humanity. https://t.co/y37SdFHthe— The Associated Press (@AP) November 30, 2022
A member of the Royal household at Buckingham Palace has resigned after repeatedly asking a black visitor where she was "really from." Ngozi Fulani, who said she was born in the UK, was reportedly asked by the aristocrat where "your people" come from.
Twitter has announced an end to its controversial COVID-19 moderation policy. The social media firm said it will no longer enforce its coronavirus "misinformation" rules, which have been strongly criticized for penalizing discussion – sometimes between experts – about the virus.
There have been more clashes in China as some citizens continue to express fury at the country's extreme COVID-19 restrictions. Videos posted online show protesters facing off with riot police in the southern city of Guangzhou.
Unrest continues in China's Guangzhou as lockdown anger grows https://t.co/5mHfRzTxxi— BBC News (World) (@BBCWorld) November 30, 2022
In happier news, scientists have celebrated a breakthrough in the treatment of Alzheimer's disease. Researchers said a new drug – lecanemab – is the first medicine to successfully fight the debilitating illness.
The drug lecanemab slows the rate of cognitive decline among people with early Alzheimer's disease by 27 per cent, compared with placebo infusions. But some concerns still linger over the drug's safety https://t.co/2xUYHQOmT7— New Scientist (@newscientist) November 30, 2022